TUBGCP4

Across TCGA pan-cancer cohorts, TUBGCP4 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TUBGCP4 data layer compared with 26 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher TUBGCP4 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated TUBGCP4 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LUAD show a favorable association.

CCRCC, LUAD, and LSCC are the cancer types where TUBGCP4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	All	0.887	0.359	.003	20	view →
LUAD	DFS	Tertile	III,IV	0.890	0.343	.011	6	view →
LSCC	DFS	Median	All	0.902	0.469	.010	5	view →
PDAC	OS	Tertile	IV	0.934	0.425	.024	3	view →
GBM	OS	Median	All	0.905	0.805	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TUBGCP4–CCRCC (DFS)

Open the CCRCC breakdown →